A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents
Millions of patients in the United States use anticoagulation for a variety of indications, such as the prevention of stroke in those with atrial fibrillation (AF) and the treatment and prevention of venous thrombosis. For over six decades warfarin was the only available oral anticoagulant, but now...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | http://www.mdpi.com/2077-0383/7/2/29 |
id |
doaj-830b44d3faa147838464c729d22a08d8 |
---|---|
record_format |
Article |
spelling |
doaj-830b44d3faa147838464c729d22a08d82020-11-24T22:54:13ZengMDPI AGJournal of Clinical Medicine2077-03832018-02-01722910.3390/jcm7020029jcm7020029A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal AgentsStephanie A. Joppa0Justin Salciccioli1Jill Adamski2Salma Patel3Waldemar Wysokinski4Robert McBane5Farah Al-Saffar6Heidi Esser7Fadi Shamoun8Department of Cardiology, Mayo Clinic, Phoenix, AZ 85054, USAWhipps Cross University Hospital, London E11 1NR, UKDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ 85054, USACenter for Sleep Medicine, Mayo Clinic, Rochester, MN 55905, USADepartment of Cardiology, Mayo Clinic, Rochester, MN 55905, USACenter for Sleep Medicine, Mayo Clinic, Rochester, MN 55905, USADepartment of Cardiology, Mayo Clinic, Phoenix, AZ 85054, USAMidwestern University, Glendale, AZ 85308, USADepartment of Cardiology, Mayo Clinic, Phoenix, AZ 85054, USAMillions of patients in the United States use anticoagulation for a variety of indications, such as the prevention of stroke in those with atrial fibrillation (AF) and the treatment and prevention of venous thrombosis. For over six decades warfarin was the only available oral anticoagulant, but now several DOACs are available and their use has become more prevalent in recent years. In spite of this increased use, many physicians remain reluctant to prescribe DOACs due to concerns about bleeding and reversibility.http://www.mdpi.com/2077-0383/7/2/29anticoagulantsserum levelsreversal agents |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Stephanie A. Joppa Justin Salciccioli Jill Adamski Salma Patel Waldemar Wysokinski Robert McBane Farah Al-Saffar Heidi Esser Fadi Shamoun |
spellingShingle |
Stephanie A. Joppa Justin Salciccioli Jill Adamski Salma Patel Waldemar Wysokinski Robert McBane Farah Al-Saffar Heidi Esser Fadi Shamoun A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents Journal of Clinical Medicine anticoagulants serum levels reversal agents |
author_facet |
Stephanie A. Joppa Justin Salciccioli Jill Adamski Salma Patel Waldemar Wysokinski Robert McBane Farah Al-Saffar Heidi Esser Fadi Shamoun |
author_sort |
Stephanie A. Joppa |
title |
A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents |
title_short |
A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents |
title_full |
A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents |
title_fullStr |
A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents |
title_full_unstemmed |
A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents |
title_sort |
practical review of the emerging direct anticoagulants, laboratory monitoring, and reversal agents |
publisher |
MDPI AG |
series |
Journal of Clinical Medicine |
issn |
2077-0383 |
publishDate |
2018-02-01 |
description |
Millions of patients in the United States use anticoagulation for a variety of indications, such as the prevention of stroke in those with atrial fibrillation (AF) and the treatment and prevention of venous thrombosis. For over six decades warfarin was the only available oral anticoagulant, but now several DOACs are available and their use has become more prevalent in recent years. In spite of this increased use, many physicians remain reluctant to prescribe DOACs due to concerns about bleeding and reversibility. |
topic |
anticoagulants serum levels reversal agents |
url |
http://www.mdpi.com/2077-0383/7/2/29 |
work_keys_str_mv |
AT stephanieajoppa apracticalreviewoftheemergingdirectanticoagulantslaboratorymonitoringandreversalagents AT justinsalciccioli apracticalreviewoftheemergingdirectanticoagulantslaboratorymonitoringandreversalagents AT jilladamski apracticalreviewoftheemergingdirectanticoagulantslaboratorymonitoringandreversalagents AT salmapatel apracticalreviewoftheemergingdirectanticoagulantslaboratorymonitoringandreversalagents AT waldemarwysokinski apracticalreviewoftheemergingdirectanticoagulantslaboratorymonitoringandreversalagents AT robertmcbane apracticalreviewoftheemergingdirectanticoagulantslaboratorymonitoringandreversalagents AT farahalsaffar apracticalreviewoftheemergingdirectanticoagulantslaboratorymonitoringandreversalagents AT heidiesser apracticalreviewoftheemergingdirectanticoagulantslaboratorymonitoringandreversalagents AT fadishamoun apracticalreviewoftheemergingdirectanticoagulantslaboratorymonitoringandreversalagents AT stephanieajoppa practicalreviewoftheemergingdirectanticoagulantslaboratorymonitoringandreversalagents AT justinsalciccioli practicalreviewoftheemergingdirectanticoagulantslaboratorymonitoringandreversalagents AT jilladamski practicalreviewoftheemergingdirectanticoagulantslaboratorymonitoringandreversalagents AT salmapatel practicalreviewoftheemergingdirectanticoagulantslaboratorymonitoringandreversalagents AT waldemarwysokinski practicalreviewoftheemergingdirectanticoagulantslaboratorymonitoringandreversalagents AT robertmcbane practicalreviewoftheemergingdirectanticoagulantslaboratorymonitoringandreversalagents AT farahalsaffar practicalreviewoftheemergingdirectanticoagulantslaboratorymonitoringandreversalagents AT heidiesser practicalreviewoftheemergingdirectanticoagulantslaboratorymonitoringandreversalagents AT fadishamoun practicalreviewoftheemergingdirectanticoagulantslaboratorymonitoringandreversalagents |
_version_ |
1725661478997983232 |